Goldman Sachs
ZBH icon

Goldman Sachs’s Zimmer Biomet ZBH Stock Holding History

Goldman Sachs’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-50,000
Closed -$6.39M – 6775
2022
Q1 		$6.39M Buy
+50,000
New +$6.03M ﹤0.01% 3121
2020
Q4 		– Sell
-10,403
Closed -$1.38M – 5742
2020
Q3 		$1.38M Buy
10,403
+103
+1% +$13.5K ﹤0.01% 3851
2020
Q2 		$1.19M Sell
10,300
-19,673
-66% -$2.27M ﹤0.01% 3834
2020
Q1 		$2.94M Buy
+29,973
New +$3.93M ﹤0.01% 3038
2018
Q2 		– Sell
-55,517
Closed -$5.88M – 6076
2018
Q1 		$5.88M Buy
55,517
+53,663
+2,894% +$6.23M ﹤0.01% 2760
2017
Q4 		$217K Buy
+1,854
New +$210K ﹤0.01% 5388
2017
Q3 		– Sell
-1,442
Closed -$180K – 6892
2017
Q2 		$180K Buy
+1,442
New +$171K ﹤0.01% 5852
2014
Q4 		– Sell
-309
Closed -$30K – 7341
2014
Q3 		$30K Sell
309
-6,386
-95% -$628K ﹤0.01% 6933
2014
Q2 		$675K Sell
6,695
-93,318
-93% -$9.11M ﹤0.01% 5059
2014
Q1 		$9.18M Sell
100,013
-141,316
-59% -$13M ﹤0.01% 2445
2013
Q4 		$21.8M Buy
241,329
+173,246
+254% +$15M 0.01% 1672
2013
Q3 		$5.43M Sell
68,083
-59,431
-47% -$4.68M ﹤0.01% 2833
2013
Q2 		$9.28M Buy
+127,514
New +$9.53M ﹤0.01% 2164

Other funds holding ZBH

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Goldman Sachs's ZBH Position: Q2 2026 in Review

Goldman Sachs reduced its Zimmer Biomet (ZBH) stake by 11% in Q2 2026, selling an estimated $10.5M and leaving 968,628 shares worth $83.4M. The position accounts for 0.01% of the portfolio, ranked #1371.

Goldman Sachs first reported a position in ZBH in Q2 2013 and has held it in 53 quarters since. The position peaked at $3.52B in Q2 2015. 909 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Goldman Sachs held 968,628 shares of Zimmer Biomet worth $83.4M as of Q2 2026.
  • Goldman Sachs sold 119,585 Zimmer Biomet shares in Q2 2026, an estimated $10.5M.
  • Zimmer Biomet made up 0.01% of Goldman Sachs's portfolio in Q2 2026, its #1371 holding.
  • Goldman Sachs first reported a position in Zimmer Biomet in Q2 2013 and has held it in 53 quarters since.
  • Goldman Sachs's Zimmer Biomet position peaked at $3.52B in Q2 2015.
  • 909 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.